Home Cart Sign in  
Chemical Structure| 14659-58-6 Chemical Structure| 14659-58-6

Structure of 14659-58-6

Chemical Structure| 14659-58-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 14659-58-6 ]

CAS No. :14659-58-6
Formula : C8H8BrF
M.W : 203.05
SMILES Code : CC1=C(Br)C(C)=CC(F)=C1
MDL No. :MFCD09864702
InChI Key :SIZYXYRNXJSAON-UHFFFAOYSA-N
Pubchem ID :44717723

Safety of [ 14659-58-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 14659-58-6 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 6
Fraction Csp3 0.25
Num. rotatable bonds 0
Num. H-bond acceptors 1.0
Num. H-bond donors 0.0
Molar Refractivity 44.03
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

0.0 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.49
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

4.2
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.63
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

4.1
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

3.84
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

3.65

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-4.19
Solubility 0.0131 mg/ml ; 0.0000647 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.91
Solubility 0.025 mg/ml ; 0.000123 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-4.31
Solubility 0.00999 mg/ml ; 0.0000492 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

Low
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-4.56 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<2.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.35

Application In Synthesis of [ 14659-58-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 14659-58-6 ]

[ 14659-58-6 ] Synthesis Path-Downstream   1~41

  • 2
  • [ 14659-58-6 ]
  • [ 38380-18-6 ]
  • 6
  • [ 14659-58-6 ]
  • [ 14659-61-1 ]
  • [ 404337-40-2 ]
  • 7
  • [ 14659-58-6 ]
  • [ 544-92-3 ]
  • [ 14659-61-1 ]
  • 9
  • [ 14659-58-6 ]
  • 4-fluoro-1-(4-fluoro-2,6-dimethylphenyl)-6-methyl-1,2-dihydrobenzocyclobutene [ No CAS ]
  • 11
  • [ 14659-58-6 ]
  • [ 404337-40-2 ]
  • 13
  • [ 14659-58-6 ]
  • [ 38380-17-5 ]
  • 14
  • [ 3095-38-3 ]
  • [ 14659-58-6 ]
  • 15
  • [ 315-12-8 ]
  • [ 14659-58-6 ]
  • 16
  • [ 34761-82-5 ]
  • [ 14659-58-6 ]
  • 17
  • [ 19023-45-1 ]
  • [ 14659-58-6 ]
  • 18
  • [ 1253927-92-2 ]
  • [ 14659-58-6 ]
  • 19
  • [ 19821-80-8 ]
  • [ 14659-58-6 ]
  • [ 1318253-19-8 ]
  • 20
  • [ 14659-58-6 ]
  • [ 1318253-04-1 ]
  • 21
  • [ 14659-58-6 ]
  • [ 1318253-25-6 ]
  • 22
  • [ 14659-58-6 ]
  • [2,6-bis(4-fluoro-2,6-dimethylphenyl)phenyl]dimethylsilylium tetrakis(pentafluorophenyl)borate - acetonitrile-d3 complex [ No CAS ]
  • 23
  • [ 121-43-7 ]
  • [ 14659-58-6 ]
  • [ 1392512-54-7 ]
  • 24
  • [ 14659-58-6 ]
  • [ 1392512-22-9 ]
  • 25
  • [ 14659-58-6 ]
  • [ 1392512-46-7 ]
  • 26
  • [ 14659-58-6 ]
  • [ 1435747-81-1 ]
  • 27
  • [ 14659-58-6 ]
  • [ 613234-55-2 ]
  • 28
  • [ 14659-58-6 ]
  • [ 1435748-16-5 ]
  • [ 1435748-21-2 ]
  • 29
  • [ 626-05-1 ]
  • [ 14659-58-6 ]
  • [ 1610475-24-5 ]
  • 30
  • [ 745783-97-5 ]
  • [ 14659-58-6 ]
  • C14H19BBrFO2 [ No CAS ]
  • 31
  • [ 626-05-1 ]
  • [ 14659-58-6 ]
  • C13H11BrFN [ No CAS ]
  • 32
  • [ 14659-58-6 ]
  • [ 75998-29-7 ]
  • (3-chloro-6-methoxybenzo[b]thiophen-2-yl)(4-fluoro-2,6-dimethylphenyl)methanone [ No CAS ]
  • 33
  • [ 14659-58-6 ]
  • (3-(4-bromophenoxy)-6-methoxybenzo[b]thiophen-2-yl)(4-fluoro-2,6-dimethylphenyl)methanone [ No CAS ]
  • 34
  • [ 14659-58-6 ]
  • (3-(4-bromophenoxy)-6-hydroxybenzo[b]thiophen-2-yl)(4-fluoro-2,6-dimethylphenyl)methanone [ No CAS ]
  • 35
  • [ 14659-58-6 ]
  • methyl (E)-3-(4-((2-(4-fluoro-2,6-dimethylbenzoyl)-6-hydroxybenzo[b]thiophen-3-yl)oxy)phenyl)acrylate [ No CAS ]
  • 36
  • [ 14659-58-6 ]
  • (E)-3-(4-((2-(4-fluoro-2,6-dimethylbenzoyl)-6-hydroxybenzo[b]thiophen-3-yl)oxy)phenyl)acrylic acid [ No CAS ]
  • 37
  • [ 14659-58-6 ]
  • N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl]-6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide [ No CAS ]
  • 38
  • [ 14659-58-6 ]
  • [ 2338-56-9 ]
YieldReaction ConditionsOperation in experiment
90% With tris-(dibenzylideneacetone)dipalladium(0); potassium hydroxide; tert-butyl XPhos; In 1,4-dioxane; water; at 100℃;Inert atmosphere; A 1L three-necked round-bottomed flask equipped with a magnetic stir bar was charged with di-tert-butyl (2', 4', 6'-triisopropyl- [1, 1'-biphenyl] -2-yl) phosphine (8.37 g, 19.70 mmol) , tris (dibenzylideneacetone) dipalladium (4.51 g, 4.92 mmol) and potassium hydroxide (41.4 g, 739 mmol) . The flask was evacuated and backfilled with nitrogen. Separately, dioxane (150 mL) , 2-bromo-5-fluoro-1, 3-dimethylbenzene (50 g, 246 mmol) and water (150 mL) were flow purged with nitrogen for about 30 minutes and were transferred to the reaction flask via a cannula. The reaction vessel was heated to about 100 C and stirred overnight. The reaction mixture was cooled to ambient temperature. The reaction mixture was acidified to pH 2 by adding 6N HCl and the product was extracted with dichloromethane (3 x 250 mL) . The combined organic layers were stirred with mercaptopropyl silica gel for about 30 minutes, dried over anhydrous magnesium sulfate, filtered, and concentrated to afford the title compound as a white solid. (31.2 g, 223 mmol, 90% yield)
90% With tris-(dibenzylideneacetone)dipalladium(0); water; potassium hydroxide; tert-butyl XPhos; In 1,4-dioxane;Inert atmosphere; A 1L three-necked round-bottomed flask equipped with a magnetic stir bar was charged with di-tert-butyl(2?,4?,6?-triisopropyl-[ 1,1 ?-biphenyll -2-yl)phosphine (8.37 g, 19.70mmol), tris(dibenzylideneacetone)dipalladium (4.51 g, 4.92 mmol) and potassium hydroxide (41.4 g, 739 mmol). The flask was evacuated and backfilled with nitrogen. Separately, dioxane (150 mL), <strong>[14659-58-6]2-bromo-5-fluoro-1,3-dimethylbenzene</strong> (50 g, 246 mmol) and water (150 mL) were flow purged with nitrogen for about 30 minutes and were transferred to the reaction flask via a cannula. The reaction vessel was heated to about 100 C and stirredovernight. The reaction mixture was cooled to ambient temperature, acidified to pH 2 by adding 6N HC1, and extracted with dichloromethane (3 x 250 mL). The combined organic layers were stirred with mercaptopropyl silica gel for about 30 minutes, dried over anhydrous magnesium sulfate, filtered, and concentrated to provide the title compound as a white solid. (31.2 g, 223 mmol, 90% yield)
86% n-Butyllithium (11 mL, 17.7 mmol, 1.6 M) was added dropwise to <strong>[14659-58-6]2-bromo-5-fluoro-1,3-dimethylbenzene</strong> (3 g, 14.8 mmol) in tetrahydrofuran (30 mL). ) in solution.The reaction solution was stirred at -78 C for 30 minutes under nitrogen atmosphere.Then trimethyl borate (1.84 g, 17.7 mmol). After the completion of the dropwise addition, the reaction solution was slowly warmed to room temperature and stirred for 12 hours. A solution of sodium hydroxide (0.88 g, 22 mmol) in hydrogen peroxide (24 mL, 30% w/w) was added dropwise to the reaction mixture at -15 C. After completion of the dropwise addition, the reaction mixture was stirred at room temperature for 3 hr. Ethyl acetate (75 mL * 2) was extracted, washed with saturated brine (100 mL*3), and evaporated After column separation (petroleum ether: ethyl acetate = 5:1), 4-fluoro-2,6-dimethylphenol (1.8 g, 12.73 mmol, yield: 86%) was obtained.
67% A solution of <strong>[14659-58-6]2-bromo-5-fluoro-1,3-dimethylbenzene</strong> (25 g, 123 mmol) in tetrahydrofuran (300 mL) was cooled to -78 C and n-butyllithium (59.1 mL, 148 mmol) wasadded dropwise at a rate to keep the internal temperature at or below -75 C. The mixture was stirred for 2 hours and then trimethylborate (16.51 mL, 148 mmol) was added and the mixture stirred for 3 hours at -78 C, then warmed to ambient temperature. After 4 hours, the mixture was cooled to -10 C and a precooled solution of NaOH (7.39 g, 185 mmol) and 30 % hydrogen peroxide (201 mL, 1970 mmol) was added. Once the addition was completethe mixture was allowed to warm to ambient temperature overnight. The pH of the mixture was adjusted to pH 1 with 2M HC1. 400 mL of ethyl ether and 200 mL of water were added and the layers were separated. The aqueous layer was extracted with 3 x 200 mL of ether, and the combined organic layers were washed with saturated NaHCO3 and saturated Na5203, then stirred with a saturated aqueous Na5205 solution (200 mL) for 15 minutes. The organicphase was dried with anhydrous magnesium sulfate, filtered, and concentrated. The residues were taken up in 1/1 diethyl ether/pentane and flushed through a silica plug. Concentration of the filtrate provided 11 .47g (67%) of the title compound.

  • 39
  • [ 14659-58-6 ]
  • methyl 3-bromo-4-(4-fluoro-2,6-dimethylphenoxy)benzoate [ No CAS ]
  • 40
  • [ 14659-58-6 ]
  • 2-(3-bromo-4-(4-fluoro-2,6-dimethylphenoxy)phenyl)propane-2-ol [ No CAS ]
  • 41
  • [ 14659-58-6 ]
  • ethyl 4-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-6-methyl-7-oxo-1-tosyl-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 14659-58-6 ]

Fluorinated Building Blocks

Chemical Structure| 452-63-1

A563621 [452-63-1]

1-Bromo-4-fluoro-2-methylbenzene

Similarity: 0.95

Chemical Structure| 1422-53-3

A346991 [1422-53-3]

2-Bromo-4-fluorotoluene

Similarity: 0.93

Chemical Structure| 875664-38-3

A355995 [875664-38-3]

1-Bromo-4,5-difluoro-2-methylbenzene

Similarity: 0.88

Chemical Structure| 61150-57-0

A408281 [61150-57-0]

2-Bromo-4-fluorobenzylbromide

Similarity: 0.88

Chemical Structure| 127425-73-4

A761143 [127425-73-4]

1-Bromo-4-(bromomethyl)-2-fluorobenzene

Similarity: 0.88

Aryls

Chemical Structure| 452-63-1

A563621 [452-63-1]

1-Bromo-4-fluoro-2-methylbenzene

Similarity: 0.95

Chemical Structure| 1422-53-3

A346991 [1422-53-3]

2-Bromo-4-fluorotoluene

Similarity: 0.93

Chemical Structure| 875664-38-3

A355995 [875664-38-3]

1-Bromo-4,5-difluoro-2-methylbenzene

Similarity: 0.88

Chemical Structure| 61150-57-0

A408281 [61150-57-0]

2-Bromo-4-fluorobenzylbromide

Similarity: 0.88

Chemical Structure| 127425-73-4

A761143 [127425-73-4]

1-Bromo-4-(bromomethyl)-2-fluorobenzene

Similarity: 0.88

Bromides

Chemical Structure| 452-63-1

A563621 [452-63-1]

1-Bromo-4-fluoro-2-methylbenzene

Similarity: 0.95

Chemical Structure| 1422-53-3

A346991 [1422-53-3]

2-Bromo-4-fluorotoluene

Similarity: 0.93

Chemical Structure| 875664-38-3

A355995 [875664-38-3]

1-Bromo-4,5-difluoro-2-methylbenzene

Similarity: 0.88

Chemical Structure| 61150-57-0

A408281 [61150-57-0]

2-Bromo-4-fluorobenzylbromide

Similarity: 0.88

Chemical Structure| 127425-73-4

A761143 [127425-73-4]

1-Bromo-4-(bromomethyl)-2-fluorobenzene

Similarity: 0.88